Latest topics page 24
Topics ordered by most recent activity across all 71 subcategories.
1,535 topics · page 24 of 52
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Rotating between abdomen, thigh and upper arm: absorption differences
On the subject in the title: Rotating between abdomen, thigh and upper arm: absorption differences Working notes rather than a conclusion. Reporting something rather than asking about it, in case the pattern…
|
2 | 3.5k | 5mo | |
|
The most common factual error about semaglutide on the internet — what changed since
The most common factual error about semaglutide on the internet — what changed since — setting out what I have, and where I think it stops being reliable. Comparing SURMOUNT-2 ( Lancet , 2023) with STEP 1 ( N…
|
+42 | 46 | 1.7k | 5mo |
|
Absence of evidence and evidence of absence
Absence of evidence and evidence of absence Writing it up because I had to work it out twice and would rather nobody else did. Session topic: SURMOUNT-OSA ( N Engl J Med , 2024). Please read it before…
|
+16 | 20 | 3.9k | 5mo |
|
A genuinely late dose: what the labelling says and what people do
On the subject in the title: A genuinely late dose: what the labelling says and what people do Working notes rather than a conclusion. Reporting something rather than asking about it, in case the pattern is…
|
2 | 18k | 5mo | |
|
Reading a regulatory notice rather than an article about it
Posting this under the heading it deserves: Reading a regulatory notice rather than an article about it Everything below is what sits behind that. Structured report rather than an opinion, following the…
|
2 | 2.9k | 5mo | |
|
Waist circumference technique and its repeatability
Waist circumference technique and its repeatability — setting out what I have, and where I think it stops being reliable. Maintenance rather than loss, which is the part of this that almost nobody writes…
|
+55 | 60 | 11k | 5mo |
|
What I would record differently if I started again
Asking directly, because I could not find a straight answer: What I would record differently if I started again Maintenance rather than loss, which is the part of this that almost nobody writes about. I have…
|
2 | 12k | 5mo | |
|
Interpreting a result that disagrees with the supplier's certificate
Interpreting a result that disagrees with the supplier's certificate Writing it up because I had to work it out twice and would rather nobody else did. Structured report rather than an opinion, following the…
|
+129 | 153 | 7.3k | 5mo |
|
The lowest dose that does anything: is that a real question?
Asking directly, because I could not find a straight answer: The lowest dose that does anything: is that a real question? I have read the maintained page on this and I still have a gap, so I am asking rather…
|
+100 | 111 | 9.1k | 5mo |
|
"Greater than or equal to 99%" as a specification rather than a result
"Greater than or equal to 99%" as a specification rather than a result Writing it up because I had to work it out twice and would rather nobody else did. Working through the identity arithmetic and I would…
|
+132 | 146 | 47k | 5mo |
|
Journal club: PIONEER 6 as a safety trial
Posting this under the heading it deserves: Journal club: PIONEER 6 as a safety trial Everything below is what sits behind that. Session topic: SURMOUNT-4 ( JAMA , 2024). Please read it before posting; the…
|
+14 | 18 | 262 | 5mo |
|
Revisiting: Language barriers in accessing a prescription abroad
Posting this under the heading it deserves: Revisiting: Language barriers in accessing a prescription abroad Everything below is what sits behind that. Documenting an access outcome, dated, because everything…
|
+131 | 148 | 28k | 5mo |
|
[2026 update] Confounding by indication, explained with a concrete example
Confounding by indication, explained with a concrete example Writing it up because I had to work it out twice and would rather nobody else did. I have seen SURPASS-4 ( Lancet , 2021) cited in support of a…
|
+103 | 116 | 22k | 5mo |
|
Contributing data without breaching anyone's privacy
Contributing data without breaching anyone's privacy Writing it up because I had to work it out twice and would rather nobody else did. I would like to understand what this number means before I repeat it…
|
+65 | 71 | 839 | 5mo |
|
Follow-up: Bug report: the reconstitution calculator and a rounding edge case
On the subject in the title: Bug report: the reconstitution calculator and a rounding edge case Working notes rather than a conclusion. Working through the identity arithmetic and I would like it checked.…
|
+58 | 63 | 24k | 5mo |
|
[2026 update] Amylin and gastric emptying: overlapping mechanisms with incretins
Amylin and gastric emptying: overlapping mechanisms with incretins — setting out what I have, and where I think it stops being reliable. Session topic: FLOW ( N Engl J Med , 2024). Please read it before…
|
+21 | 25 | 44k | 5mo |
|
Storing lyophilised material long term: what governs the shelf life
On the subject in the title: Storing lyophilised material long term: what governs the shelf life Working notes rather than a conclusion. Practical question with the units stated, because I have seen how…
|
+83 | 90 | 1k | 5mo |
|
Why semaglutide's albumin binding is the whole reason weekly dosing works
Asking directly, because I could not find a straight answer: Why semaglutide's albumin binding is the whole reason weekly dosing works Session topic: SELECT ( N Engl J Med , 2023). Please read it before…
|
2 | 63k | 5mo | |
|
Revisiting: A page that has drifted out of date and needs a maintainer
Revisiting: A page that has drifted out of date and needs a maintainer Writing it up because I had to work it out twice and would rather nobody else did. Nominating something for promotion into the…
|
+112 | 119 | 8.8k | 5mo |
|
Peer-to-peer review: what actually happens on the call — one year on
Peer-to-peer review: what actually happens on the call — one year on — setting out what I have, and where I think it stops being reliable. Documenting an access outcome, dated, because everything in this…
|
+2 | 6 | 41k | 5mo |
|
Research-use-only labelling: what it means and what it does not
Posting this under the heading it deserves: Research-use-only labelling: what it means and what it does not Everything below is what sits behind that. I would like to talk about documentation quality as a…
|
+100 | 110 | 37k | 5mo |
|
[2026 update] Journal club: PIONEER 6 as a safety trial
Journal club: PIONEER 6 as a safety trial Writing it up because I had to work it out twice and would rather nobody else did. I have seen SUSTAIN 6 ( N Engl J Med , 2016) cited in support of a claim I do not…
|
+14 | 18 | 55k | 5mo |
|
Follow-up: "Should I double up?" — answered once, at length, calmly
On the subject in the title: "Should I double up?" — answered once, at length, calmly Working notes rather than a conclusion. I have read the maintained page on this and I still have a gap, so I am asking…
|
2 | 9.7k | 5mo | |
|
Dead volume across syringe and needle combinations
On the subject in the title: Dead volume across syringe and needle combinations Working notes rather than a conclusion. Practical question with the units stated, because I have seen how quickly these go wrong…
|
+72 | 80 | 28k | 5mo |
|
Specification in the result column: why that is a meaningful error
Posting this under the heading it deserves: Specification in the result column: why that is a meaningful error Everything below is what sits behind that. Working through the identity arithmetic and I would…
|
+107 | 129 | 41k | 5mo |
|
Coming back to: Reading a supplier's product description as a marketing document
Reading a supplier's product description as a marketing document Writing it up because I had to work it out twice and would rather nobody else did. I have seen SUSTAIN 6 ( N Engl J Med , 2016) cited in…
|
+35 | 39 | 688 | 5mo |
|
Measurement error in a self-reported exposure
Posting this under the heading it deserves: Measurement error in a self-reported exposure Everything below is what sits behind that. Session topic: SURPASS-2 ( N Engl J Med , 2021). Please read it before…
|
+117 | 129 | 45k | 5mo |
|
Reading SURMOUNT-1 without the press release — one year on
Reading SURMOUNT-1 without the press release — one year on — setting out what I have, and where I think it stops being reliable. I have seen LEADER ( N Engl J Med , 2016) cited in support of a claim I do not…
|
+45 | 50 | 7.6k | 5mo |
|
Second pass at: Where impurities in solid-phase peptide synthesis come from
Posting this under the heading it deserves: Second pass at: Where impurities in solid-phase peptide synthesis come from Everything below is what sits behind that. A documentation question rather than an…
|
+47 | 51 | 3.3k | 5mo |
|
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes
The SOUL trial and oral semaglutide cardiovascular outcomes — setting out what I have, and where I think it stops being reliable. I have seen LEADER ( N Engl J Med , 2016) cited in support of a claim I do not…
|
+100 | 104 | 4.2k | 5mo |